BLANDIZZI, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 32.477
AS - Asia 15.669
EU - Europa 12.429
SA - Sud America 2.169
AF - Africa 726
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 16
Totale 63.549
Nazione #
US - Stati Uniti d'America 31.592
SG - Singapore 4.734
CN - Cina 4.353
IT - Italia 4.001
HK - Hong Kong 2.468
SE - Svezia 2.018
BR - Brasile 1.800
VN - Vietnam 1.360
DE - Germania 1.297
BG - Bulgaria 1.062
GB - Regno Unito 806
TR - Turchia 687
CA - Canada 666
FR - Francia 649
FI - Finlandia 574
UA - Ucraina 559
RU - Federazione Russa 531
IN - India 431
KR - Corea 404
JP - Giappone 291
CI - Costa d'Avorio 267
AT - Austria 242
CH - Svizzera 202
BD - Bangladesh 141
IQ - Iraq 123
AR - Argentina 113
MX - Messico 113
NL - Olanda 111
ID - Indonesia 97
NG - Nigeria 95
SN - Senegal 95
PK - Pakistan 84
BE - Belgio 83
UZ - Uzbekistan 75
PL - Polonia 74
ZA - Sudafrica 66
SA - Arabia Saudita 64
VE - Venezuela 60
AU - Australia 55
EC - Ecuador 55
CO - Colombia 48
ES - Italia 44
PH - Filippine 44
MY - Malesia 43
MA - Marocco 39
EG - Egitto 32
KE - Kenya 31
AZ - Azerbaigian 29
JO - Giordania 28
AE - Emirati Arabi Uniti 27
PY - Paraguay 27
PE - Perù 23
PT - Portogallo 23
TH - Thailandia 22
CL - Cile 21
LT - Lituania 20
NP - Nepal 20
TN - Tunisia 20
JM - Giamaica 18
BJ - Benin 16
GR - Grecia 16
IL - Israele 16
IE - Irlanda 14
IR - Iran 14
KZ - Kazakistan 14
CR - Costa Rica 13
CZ - Repubblica Ceca 13
OM - Oman 13
TW - Taiwan 13
KG - Kirghizistan 12
PA - Panama 12
DZ - Algeria 11
ET - Etiopia 11
EU - Europa 11
PS - Palestinian Territory 11
TT - Trinidad e Tobago 11
HN - Honduras 10
RO - Romania 10
UY - Uruguay 10
AL - Albania 9
DO - Repubblica Dominicana 9
BO - Bolivia 8
BY - Bielorussia 8
LB - Libano 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
AO - Angola 7
BB - Barbados 7
DK - Danimarca 7
LV - Lettonia 7
RS - Serbia 7
SY - Repubblica araba siriana 7
GE - Georgia 6
KH - Cambogia 6
SI - Slovenia 6
BW - Botswana 5
CG - Congo 5
GT - Guatemala 5
HR - Croazia 5
HU - Ungheria 5
Totale 63.451
Città #
Woodbridge 3.244
Ashburn 3.170
Ann Arbor 2.756
Singapore 2.652
Hong Kong 2.418
Fairfield 2.354
Houston 2.044
Chandler 1.937
Santa Clara 1.582
San Jose 1.544
Dallas 1.420
Sofia 1.058
Shanghai 907
Milan 906
Seattle 895
Beijing 891
Wilmington 838
Cambridge 802
Serra 795
New York 682
Jacksonville 650
Ottawa 535
Hefei 509
Boardman 499
Princeton 455
Los Angeles 440
Lawrence 405
Izmir 388
Seoul 376
Lauterbourg 371
Medford 358
Nanjing 313
Ho Chi Minh City 289
Abidjan 267
Tokyo 263
Des Moines 254
Florence 222
Hanoi 217
Dong Ket 212
London 211
Council Bluffs 208
Istanbul 201
Dearborn 190
Bern 175
Vienna 172
Buffalo 158
Helsinki 157
Frankfurt am Main 155
São Paulo 144
Munich 143
Redondo Beach 131
Rome 129
Nanchang 121
Jüchen 113
Pisa 112
Redwood City 112
The Dalles 112
Bremen 107
San Diego 105
Columbus 104
Dakar 95
Lagos 90
Brussels 80
Falls Church 77
Turku 75
Lancaster 72
Rio de Janeiro 72
Kunming 69
Chicago 67
Washington 66
Marseille 65
Ogden 65
Tashkent 65
Norwalk 64
Orem 63
Shenyang 60
Hebei 59
Tianjin 58
Boulder 56
Changsha 54
Düsseldorf 53
Phoenix 51
Pune 51
Jakarta 49
Warsaw 48
Belo Horizonte 47
Jiaxing 45
Toronto 45
Chennai 43
Da Nang 43
Curitiba 42
Baghdad 41
Guangzhou 40
Haiphong 40
Fuzhou 37
Mumbai 37
Auburn Hills 35
San Francisco 34
Nuremberg 32
Manchester 31
Totale 45.194
Nome #
Derivati isoindolici come attivatori di AMPK 533
Preparation of isoindoline derivatives for use as AMPK activators 343
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 304
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 296
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 272
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 270
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 265
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 262
Derivati benzofuranici come attivatori di AMPK 250
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 249
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis 239
A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties 238
Effects of suramin on gastric ulceration and EGF content of submandibular glands 235
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 231
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 229
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID) 228
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 226
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 225
Functional evidence that alpha-2A-adrenoceptors are responsible for anti-lipolysis in human abdominal cells 223
Altered expression pattern of molecular factors involved in colonic smooth muscle functions : an immunohistochemical study in patients with diverticular disease 221
Alpha-2 adrenoceptors and gastric secretion in dogs: The role of gastrin 220
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 219
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis 219
Fisiopatologia e farmacologia del vomito 218
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 216
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 216
Excitatory and inhibitory cholinergic effects of yohimbine on isolated guinea-pig small intestine 215
Connective remodelling in the colonic neuromuscular compartment of patients with ulcerative colitis 215
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 213
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 211
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 211
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 209
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 208
Alpha-2 adrenoceptors and gastric secretion in dogs: the role of gastrin 205
Characterization of mechanisms accounting for COX-2-mediated proliferative actions of gastrin on human colon cancer cells 205
Periodontal tissue disposition of azithromycin 205
Alpha-2A adrenoceptor subtypes modulate cholinergic contractile activity of guinea-pig ileum 203
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 203
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 203
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 203
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis 203
Quinolonecarboxylic acid derivatives as GABA-A receptor antagonists 202
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 202
Role of a2-adrenoceptors on gastrin release in the dog 200
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 199
Gabapentin-induced severe myopathy: a case report 198
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 198
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 198
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 198
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 197
Targeting enteric neuroplasticity: Diet and bugs as new key factors 196
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 196
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 196
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 195
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 195
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 195
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 195
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 194
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 194
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 194
GABA-A-mediated gastrin release induced by baclofen in the isolated vascularly perfused rat stomach 193
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 193
Alteration of endogenous purinergic modulation of tracheal neurotransmission in sensitised guinea-pigs 193
Molecular cloning of the canine gastrin/CCK-B receptor gene 192
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 192
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 192
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 192
PERIODONTAL TISSUE DISTRIBUTION OF CEFPODOXIME PROXETIL AND EFFICACY IN ACUTE ODONTOGENIC INFECTIONS 190
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 190
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 190
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients 189
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 189
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 188
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 188
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 188
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 188
Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders 187
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials 187
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 187
Healthy volunteers and early phases of clinical experimentation 186
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion 186
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 185
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 185
A tonic inhibitory control of rat pepsin secretion is mediated by central GABA-A receptors 185
Modulation of gastric acid secretion by peripheral presynaptic alpha-2 adrenoceptors at both sympathetic and parasympathetic pathways 184
Role of A2a adenosine in the regulation of colonic motility in normal human colon 184
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 184
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan. 184
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 184
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 184
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 184
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 183
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 183
Peripheral 2-hydroxy-saclofen-sensitive GABA-B receptors mediate both vagal-dependent and vagal-independent acid secretory responses in rats 182
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 182
Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study 181
Colonic smooth muscle cells and interstitial cells of Cajal in diverticular disease 181
Histopathology in gastrointestinal neuromuscular diseases: methodological and ontological issues 181
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 181
Totale 21.050
Categoria #
all - tutte 182.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021953 0 0 0 0 0 0 0 0 0 0 212 741
2021/20224.805 113 278 190 357 868 679 144 269 220 156 259 1.272
2022/20236.147 735 832 400 591 681 846 89 455 1.050 42 387 39
2023/20244.453 575 466 548 303 637 771 170 164 70 118 192 439
2024/202513.173 67 508 183 808 1.205 1.353 1.065 646 1.331 1.821 1.437 2.749
2025/202613.436 1.072 1.763 1.699 988 1.407 1.254 2.204 628 834 1.293 294 0
Totale 64.516